These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. Krajcik RA, Borofsky ND, Massardo S, Orentreich N. Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045 [Abstract] [Full Text] [Related]
3. Relationships between plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3 and second breast cancer risk in a prevention trial of fenretinide. Decensi A, Veronesi U, Miceli R, Johansson H, Mariani L, Camerini T, Di Mauro MG, Cavadini E, De Palo G, Costa A, Perloff M, Malone WF, Formelli F. Clin Cancer Res; 2003 Oct 15; 9(13):4722-9. PubMed ID: 14581342 [Abstract] [Full Text] [Related]
8. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer. Johansson H, Baglietto L, Guerrieri-Gonzaga A, Bonanni B, Mariette F, Macis D, Serrano D, Sandri MT, Decensi A. Breast Cancer Res Treat; 2004 Nov 15; 88(1):63-73. PubMed ID: 15538047 [Abstract] [Full Text] [Related]
12. Serum levels of insulin-like growth factor-I and -II and insulin-like growth factor binding protein 3 in women with squamous intraepithelial lesions and cervical cancer. Serrano ML, Romero A, Cendales R, Sánchez-Gómez M, Bravo MM. Biomedica; 2006 Jun 15; 26(2):258-68. PubMed ID: 16925098 [Abstract] [Full Text] [Related]
14. Effect of long-term treatment with raloxifene on mammary density in postmenopausal women. Lasco A, Gaudio A, Morini E, Morabito N, Nicita-Mauro C, Catalano A, Denuzzo G, Sansotta C, Xourafa A, Macrì I, Frisina N. Menopause; 2006 Jun 15; 13(5):787-92. PubMed ID: 16912660 [Abstract] [Full Text] [Related]
15. Nested case-control study of the association of circulating levels of serum insulin-like growth factor I and insulin-like growth factor binding protein 3 with breast cancer in young women in Norway. Vatten LJ, Holly JM, Gunnell D, Tretli S. Cancer Epidemiol Biomarkers Prev; 2008 Aug 15; 17(8):2097-100. PubMed ID: 18708402 [Abstract] [Full Text] [Related]
16. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Giovannucci E, Pollak MN, Platz EA, Willett WC, Stampfer MJ, Majeed N, Colditz GA, Speizer FE, Hankinson SE. Cancer Epidemiol Biomarkers Prev; 2000 Apr 15; 9(4):345-9. PubMed ID: 10794477 [Abstract] [Full Text] [Related]
17. A two-by-two factorial trial comparing oral with transdermal estrogen therapy and fenretinide with placebo on breast cancer biomarkers. Decensi A, Bonanni B, Baglietto L, Guerrieri-Gonzaga A, Ramazzotto F, Johansson H, Robertson C, Marinucci I, Mariette F, Sandri MT, Daldoss C, Bianco V, Buttarelli M, Cazzaniga M, Franchi D, Cassano E, Omodei U. Clin Cancer Res; 2004 Jul 01; 10(13):4389-97. PubMed ID: 15240527 [Abstract] [Full Text] [Related]